(Q43626562)

25 November 2017

title

Rates of hospitalisation for influenza, respiratory syncytial virus and human metapneumovirus among infants and young children (English)

1 reference

25 November 2017

1 reference

Human metapneumovirus

object named as

human metapneumovirus

1 reference

Karl G Nicholson

1

1 reference

25 November 2017

Teresa McNally

2

1 reference

25 November 2017

Michael Silverman

3

1 reference

25 November 2017

Paul Simons

4

1 reference

25 November 2017

Joanne D Stockton

5

1 reference

25 November 2017

Maria C Zambon

6

1 reference

25 November 2017

language of work or name

English

0 references

publication date

25 February 2005

1 reference

25 November 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

25 November 2017

volume

24

1 reference

25 November 2017

issue

1

1 reference

25 November 2017

page(s)

102-108

1 reference

Systematic review and economic decision modelling for the prevention and treatment of influenza A and B.

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.004

Respiratory syncytial virus or influenza?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.004

Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: an observational study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.004

A newly discovered human pneumovirus isolated from young children with respiratory tract disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.004

Characterization of human metapneumoviruses isolated from patients in North America

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.004

Presence of the new human metapneumovirus in French children with bronchiolitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.004

Children with respiratory disease associated with metapneumovirus in Hong Kong

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.004

Human metapneumovirus infections in hospitalized children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.004

Influenza and the rates of hospitalization for respiratory disease among infants and young children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.004

The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.004

The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.004

Impact of influenza and respiratory syncytial virus on mortality in England and Wales from January 1975 to December 1990.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.004

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.004

Respiratory syncytial virus infection in young hospitalized children. Identification of risk patients and prevention of nosocomial spread by rapid diagnosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.004

Incidence of respiratory syncytial virus-positive hospitalizations in Germany.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.004

Contribution of RSV to bronchiolitis and pneumonia-associated hospitalizations in English children, April 1995-March 1998.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.004

The incidence of influenza-associated hospitalizations in children in Germany.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.004

Diagnosis of influenza in the community: relationship of clinical diagnosis to confirmed virological, serologic, or molecular detection of influenza

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.004

Influenza-A infection in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.004

Influenza A and B virus infections in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.004

Influenza virus infections in infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.004

Impact of Influenza Virus Infection as a Cause of Pediatric Hospitalization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.004

Protection of infants from infection with influenza A virus by transplacentally acquired antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.004

Effect of passive maternal antibody on influenza illness in children: a prospective study of influenza A in mother-infant pairs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.004

Clinical signs and symptoms predicting influenza infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.004

Multiplex PCR for typing and subtyping influenza and respiratory syncytial viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.004

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2005.02.004

1 reference

25 November 2017

1 reference